Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tania Gonzalez-Rivera

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Autoimmunity|February 26, 2013
Overexpression of X-linked genes in T cells from women with lupusAnura Hewagama, Gabriela Gorelik, Dipak Patel, et al.
Lupus|July 9, 2021
10 Years of belimumab experience: What have we learnt?Roger A Levy, Tania Gonzalez-Rivera, Munther Khamashta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2012
Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritisCeline C Berthier, Ramalingam Bethunaickan, Tania Gonzalez-Rivera, et al.
Lupus Science & Medicine|December 28, 2018
Clinical response beyond the Systemic Lupus Erythematosus Responder Index: post-hoc analysis of the BLISS-SC studyRonald F van Vollenhoven, William Stohl, Richard A Furie, et al.
Kidney International|September 24, 2021
A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritisBrad H Rovin, Richard Furie, Y K Onno Teng, et al.
Arthritis Care & Research|April 19, 2022
Impact of Belimumab on Organ Damage in Systemic Lupus ErythematosusMurray B Urowitz, Cynthia Aranow, Yumi Asukai, et al.
Molecular Therapy. Advances|May 20, 2026
Case study of resecabtagene autoleucel in a subject with diffuse cutaneous systemic sclerosis treated in the RESET-SSc trialDaniel Nunez, Jenell R Volkov, Courtney Little, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Autoimmunity|February 26, 2013
Overexpression of X-linked genes in T cells from women with lupusAnura Hewagama, Gabriela Gorelik, Dipak Patel, et al.
Lupus|July 9, 2021
10 Years of belimumab experience: What have we learnt?Roger A Levy, Tania Gonzalez-Rivera, Munther Khamashta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2012
Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritisCeline C Berthier, Ramalingam Bethunaickan, Tania Gonzalez-Rivera, et al.
Lupus Science & Medicine|December 28, 2018
Clinical response beyond the Systemic Lupus Erythematosus Responder Index: post-hoc analysis of the BLISS-SC studyRonald F van Vollenhoven, William Stohl, Richard A Furie, et al.
Kidney International|September 24, 2021
A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritisBrad H Rovin, Richard Furie, Y K Onno Teng, et al.
Arthritis Care & Research|April 19, 2022
Impact of Belimumab on Organ Damage in Systemic Lupus ErythematosusMurray B Urowitz, Cynthia Aranow, Yumi Asukai, et al.
Molecular Therapy. Advances|May 20, 2026
Case study of resecabtagene autoleucel in a subject with diffuse cutaneous systemic sclerosis treated in the RESET-SSc trialDaniel Nunez, Jenell R Volkov, Courtney Little, et al.
Pageof 1